Two other genes subject to particularly frequent mutations in lung adenocarcinomas are KRAS, encoding the K-Ras variant of the small G protein Ras (36% of cases), and TP53, encoding the tumour suppressor and transcription factor p53 (47% of cases). Here, KRAS is linked to lung adenocarcinoma.